Recombinant Mouse Pah Protein, Myc/DDK-tagged
Cat.No. : | PAH-12312M |
Product Overview : | Purified recombinant protein of Mouse phenylalanine hydroxylase (Pah), with C-terminal MYC/DDK tag, expressed in HEK293T cells. |
- Specification
- Gene Information
- Related Products
Description : | Catalyzes the hydroxylation of L-phenylalanine to L-tyrosine. |
Source : | HEK293T |
Species : | Mouse |
Tag : | Myc/DDK |
Molecular Mass : | 51.9 kDa |
Purity : | >80% as determined by SDS-PAGE and Coomassie blue staining |
Stability : | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Storage : | Store at -80 centigrade after receiving vials. |
Concentration : | >50 μg/mL as determined by microplate BCA method |
Storage Buffer : | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol. |
Gene Name : | Pah phenylalanine hydroxylase [ Mus musculus (house mouse) ] |
Official Symbol : | Pah |
Synonyms : | Pah; phenylalanine hydroxylase; AW106920; phenylalanine-4-hydroxylase; phe-4-monooxygenase; EC 1.14.16.1 |
Gene ID : | 18478 |
mRNA Refseq : | NM_008777 |
Protein Refseq : | NP_032803 |
UniProt ID : | P16331 |
Products Types
◆ Recombinant Protein | ||
PAH-1601H | Recombinant Human PAH Protein, His (Fc)-Avi-tagged | +Inquiry |
PAH-259H | Recombinant Human PAH Protein, MYC/DDK-tagged | +Inquiry |
PAH-1318H | Recombinant Human PAH Protein, His-SUMO-tagged | +Inquiry |
PAH-199H | Recombinant Human PAH Protein, MYC/DDK-tagged, C13 and N15-labeled | +Inquiry |
PAH-261H | Recombinant Human PAH Protein, Flag-tagged | +Inquiry |
◆ Lysates | ||
PAH-461HCL | Recombinant Human PAH cell lysate | +Inquiry |
◆ Assay kits | ||
Kit-0647 | p-Aminohippuric Acid Assay Kit | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionYes, several medications are available to manage the symptoms and slow the progression of PAH.
Understanding the role of proteins in PAH can lead to the development of more targeted and effective treatments, improving the quality of life for patients with PAH.
Yes, certain biomarkers, such as brain natriuretic peptide (BNP) and endothelin-1, can be indicative of PAH.
Research is ongoing in the development of protein-targeted therapies for PAH, but no specific protein-targeted drugs are widely used as of my last update in January 2022.
Protein biomarkers can help in early diagnosis, and monitoring their levels can aid in assessing disease progression and response to treatment.
Customer Reviews (3)
Write a reviewI highly recommend the use of the PAH protein in various experimental applications.
Considering its outstanding performance across multiple assays, I confidently endorse the inclusion of the PAH protein in diverse research studies.
the PAH protein has been successfully utilized in protein electron microscopy structure analysis, providing valuable insights into molecular structures and interactions.
Ask a Question for All Pah Products
Required fields are marked with *
My Review for All Pah Products
Required fields are marked with *
Inquiry Basket